A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice

Galderma logo

Galderma

Status

Completed

Conditions

Health Knowledge, Attitudes, Practice

Study type

Observational

Funder types

Industry

Identifiers

NCT01800474
05PT1209

Details and patient eligibility

About

A multe-center, non-interventional study in Europe to evaluate Pliaglis in daily practice

Full description

A multi-center, non-interventional study, including up to 700 subjects at approximately 70 sites in 5 European countries to evaluate the post-market safety profile of Pliaglis and the efficacy of Pliaglis in terms of pain reduction, satisfaction with the product and daily practice use prior to pre-defined aesthetic procedures.

Enrollment

582 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Signed informed consent

  • Patient treated with Pliaglis by the Investigator or other healthcare professional according to label (refer to SmPC)

  • Patient had already consented to receive any one or more of the following aesthetic procedures after Pliaglis administration:

    1. Pulsed-dye laser therapy
    2. Laser-assisted hair removal
    3. Non-ablative laser resurfacing
    4. Dermal filler injection
    5. Vascular access

Exclusion criteria

  • Patient treated with other injectable or topical anaesthetic(s) for the pre-defined aesthetic procedure
  • Previous participation in this study

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems